SCHEMBL1763148

SCHEMBL1763148

CN(C)Cc1cc(-c2ccccc2)n(S(=O)(=O)c2cccnc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 4/20 0.43
CHRNB2 P17787 1/20 0.43
CHRNA4 P43681 1/20 0.43
ALDH1A1 P00352 3/20 0.40
CYP2A6 P11509 4/20 0.39
CYP2C19 P33261 4/20 0.39
CYP2E1 P05181 3/20 0.39
CYP2C9 P11712 3/20 0.39
CYP2B6 P20813 3/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP11B1 P15538 1/20 0.38
KDM4E B2RXH2 1/20 0.38
NAMPT P43490 1/20 0.38
MAPK1 P28482 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
ADAMTS4 O75173 1/20 0.36
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1157191 0.99 HTR6 (0.42) HTR6CHRNB2CHRNA4ALDH1A1CYP2A6
SCHEMBL1763061 0.88 HTR6 (0.51) HTR6ALDH1A1
Hydrochloric Acid SCHEMBL1156848 0.87 HTR6 (0.50) HTR6ALDH1A1
SCHEMBL28631600 0.85 CHRNB2 (0.39) HTR6CHRNB2CHRNA4CYP3A4CYP2D6
SCHEMBL30620797 0.85 CHRNB2 (0.39) HTR6CHRNB2CHRNA4CYP3A4CYP2D6
SCHEMBL1156534 0.84 EPHX2 (0.45) HTR6ALDH1A1CYP2A6CYP2C19CYP2E1
Hydrochloric Acid SCHEMBL31481621 0.84 CHRNB2 (0.39) HTR6CHRNB2CHRNA4ALDH1A1KMT2A
Hydrochloric Acid SCHEMBL1156623 0.83 EPHX2 (0.44) HTR6ALDH1A1CYP2A6CYP2C19CYP2E1
SCHEMBL1156610 0.81 PTGER2 (0.43) ALDH1A1CYP3A4KDM4ENAMPTKMT2A
SCHEMBL1156237 0.81 PTGDR2 (0.41) ALDH1A1CYP11B1KDM4ENAMPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9186411-B2 Pharmaceutical composition TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2015-11-17 US disclosed
US-20130261156-A1 PHARMACEUTICAL COMPOSITION TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-10-03 US disclosed
EP-2564833-A1 Photostabilized pharmaceutical composition Takeda Pharmaceutical Company Limited (JP) 2013-03-06 EP disclosed
US-20110124687-A1 PHARMACEUTICAL COMPOSITION TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110124687-A1 PHARMACEUTICAL COMPOSITION CYP2C19, MLST8, CYP3A43 HTR6 1727/4885CHRNB2 4514/4885CHRNA4 4245/4885
US-20130261156-A1 PHARMACEUTICAL COMPOSITION CYP2C19, MLST8, CYP3A43 HTR6 1727/4885CHRNB2 4514/4885CHRNA4 4245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.